share_log

4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak

4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak

4：持股變動聲明-董事 Bhatt Deepak
美股SEC公告 ·  07/03 05:27
牛牛AI助理已提取核心訊息
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was involved in a market action on 06/30/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the post-transaction shareholding, were not disclosed. As such, the impact of this event on Deepak's position within the company and the total value of shares held after the action remains unclear.
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was involved in a market action on 06/30/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the post-transaction shareholding, were not disclosed. As such, the impact of this event on Deepak's position within the company and the total value of shares held after the action remains unclear.
最近有關施貴寶（BMY）的Deepak Bhatt參與了2024年6月30日的市場交易行動，交易的具體細節，包括交易股數，股票性質，交易價格和交易後的持股情況沒有公開披露，因此這一事件對Deepak在公司內的職位和行動後所持有的股票總價值的影響仍然不清楚。
最近有關施貴寶（BMY）的Deepak Bhatt參與了2024年6月30日的市場交易行動，交易的具體細節，包括交易股數，股票性質，交易價格和交易後的持股情況沒有公開披露，因此這一事件對Deepak在公司內的職位和行動後所持有的股票總價值的影響仍然不清楚。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。